Press Releases

Stay Updated

Press Releases

Donald Trump Should Keep His Promise to Lower Drug Prices

WASHINGTON, DC — In advance of tonight’s State of the Union address, Patients For Affordable Drugs Executive Director Ben Wakana issued the following statement: “Donald Trump made a campaign pledge to lower drug prices, a promise that gave hope to millions of Americans struggling to afford prescription drugs. It’s time the Trump administration put words […]

Press Releases

Momentum Building for Bipartisan CREATES Act

WASHINGTON, DC — Organizations representing patients and the research and development community today sent a letter urging Congressional leaders to pass the CREATES Act. Friends of Cancer Research, the National Multiple Sclerosis Society, and Patients For Affordable Drugs encouraged Congress to act soon to pass the bipartisan legislation that will help drive down drug prices […]

Press Releases

Statement on Luxturna’s $850,000 Price Tag

WASHINGTON, DC — The following statement was issued by David Mitchell, a patient with incurable blood cancer and the president and founder of Patients For Affordable Drugs, regarding the announcement of an $850,000 price tag for Luxturna, a new treatment that can correct a defective gene responsible for blindness in a small number of Americans. […]

Press Releases

Cancer Patients Dying Due to High Yescarta Price

WASHINGTON, DC — The following statement was issued by David Mitchell, a patient with incurable blood cancer and the president of Patients For Affordable Drugs, regarding reports of patients dying while waiting to receive Gilead’s $373,000 cancer drug, Yescarta. “My heart is breaking for these patients and their families. This situation is tragic, infuriating, and […]

Press Releases

Trump Administration Proposes Important Change To Lower Drug Prices

WASHINGTON, DC – Patients For Affordable Drugs applauded a proposal by the Trump Administration that would lower drug costs for Medicare patients. A key change in the Medicare Part D proposed rule would allow beneficiaries to pay coinsurance and deductibles based on discounted drug prices rather than the outrageous retail prices. By basing coinsurance and […]

Press Releases

Statement on the Nomination of Alex Azar as HHS Secretary

WASHINGTON, DC – Patients For Affordable Drugs Executive Director, Ben Wakana, issued the following statement regarding the nomination of Alex Azar to be the 24th Secretary of the U.S. Department of Health and Human Services. “Drug corporations have undue influence over health policy in America, and they use it to make money on the backs […]

Press Releases

Congressional Hearing to Spotlight Drug Corporation Patent Abuse

WASHINGTON, DC – The following statement was issued by David Mitchell, a cancer patient and the Founder of Patients For Affordable Drugs, regarding today’s House Judiciary Subcommittee hearing about drug company patent abuse and the inter partes review (IPR) process: “Today’s hearing touches on the heart of the problem with high drug prices. “One reason […]